TWST
Twist Bioscience Corporation
TWST lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
TWST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
TWST's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
TWST PE Valuation
TWST has no meaningful PE right now: it lost money over the past year.
TWST Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect TWST's losses to shrink, with revenue growing.
TWST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.21 | -$0.76 |
| Q1 2026 | -$1.32 | +$1.93 |
| Q4 2025 | -$1.27 | +$2.11 |
| Q3 2025 | -$1.30 | +$2.30 |
| Q2 2025 | -$1.45 | +$2.37 |
| Q1 2025 | -$3.25 | +$0.11 |
| Q4 2024 | -$3.38 | +$0.23 |
| Q3 2024 | -$3.60 | $0.00 |
TWST is still losing money, but less than at its worst: $2.21 per share over the past year, against $4.04 at its worst in late 2022.
TWST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $118.4M | +23% |
| Q1 2026 | $110.7M | +19% |
| Q4 2025 | $103.7M | +17% |
| Q3 2025 | $99M | +17% |
| Q2 2025 | $96.1M | +18% |
| Q1 2025 | $92.8M | +23% |
| Q4 2024 | $88.7M | +24% |
| Q3 2024 | $84.7M | +27% |
TWST's revenue has grown year over year every quarter since late 2020: $118M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -31% | +0.7 points |
| Q1 2026 | -41% | +3.4 points |
| Q4 2025 | -32% | +7.3 points |
| Q3 2025 | -30% | +12 points |
| Q2 2025 | -31% | +78 points |
| Q1 2025 | -45% | +20 points |
| Q4 2024 | -39% | +27 points |
| Q3 2024 | -43% | +32 points |
TWST's operating margin was −31% last quarter, up 0.7 points from the same quarter a year ago, near the top of its range since 2019.
TWST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$8.6M | +$1.9M |
| Q1 2026 | -$25.4M | -$8.3M |
| Q4 2025 | -$34.8M | -$11.1M |
| Q3 2025 | -$24.2M | -$6.9M |
| Q2 2025 | -$10.6M | -$3.2M |
| Q1 2025 | -$17.1M | +$2.9M |
| Q4 2024 | -$23.7M | +$783K |
| Q3 2024 | -$17.3M | +$5.8M |
TWST has burned cash in almost every quarter: −$93M over the past year, against −$69M the year before.
TWST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +701K shares |
| 1 year | +2% | +1.2M shares |
| 3 years | +9.4% | +5.4M shares |
| 5 years | +27% | +13.4M shares |
| Available history | +89% | +29.4M shares |
TWST has 62M diluted shares, up 2% from a year ago.
TWST Net Leverage
TWST's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TWST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.9 | Neutral |
| Stochastic | 32.4 | Neutral |
TWST's weekly RSI is 49 (neutral) and its Stochastic is 32 (neutral).
TWST PE vs Healthcare Sector
TWST has no meaningful PE right now: it lost money over the past year.
TWST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $149.0 | 23% below |
| 20 week MA | $129.9 | 12% below |
| 50 week MA | $82.7 | 38% above |
| 100 week MA | $59.4 | 92% above |
| 200 week MA | $45.3 | 152% above |
TWST has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 152% above its 200-week average.
TWST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.0 | $164.0 | +644% |
| 2021 | $164.0 | $84.5 | -48% |
| 2022 | $84.5 | $23.2 | -73% |
| 2023 | $23.2 | $36.9 | +59% |
| 2024 | $36.9 | $48.2 | +31% |
| 2025 | $48.2 | $33.1 | -31% |
| 2026 YTD | $33.1 | $114.2 | +246% |
TWST's yearly returns have swung widely, from +644% in 2020 to −73% in 2022. It's up 246% so far in 2026.